If developing drugs for metabolic dysfunction-associated steatohepatitis (MASH) were a poker game, you could say Novo Nordisk (NASDAQ Copenhagen: NOVO-B)…
Credit: Juan Gaertner/Science Photo Library/Getty Images Scientists using “disease in a dish” technology to study multiple sclerosis (MS) identified an…
Panelists: Matt Taylor Senior Process Development AssociateKBI Biopharma Panelist Matt Taylor Matt Taylor is a senior process development associate at…
Panelists: Tullia Bruno, PhD Asst. Professor, Department of ImmunologyMember, Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer CenterMember, Tumor Microenvironment…